Matches in SemOpenAlex for { <https://semopenalex.org/work/W1990627589> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W1990627589 endingPage "1130" @default.
- W1990627589 startingPage "1128" @default.
- W1990627589 abstract "Recent data have suggested enhanced therapeutic activity with prolonged administration of both etoposide as well as fluoropyrimidines in the treatment of gastrointestinal malignancies. Based on this rationale, we investigated the clinical effectiveness and tolerance of an oral modification of the widely applied etoposide, leucovorin and 5-fluorouracil (ELF) regimen in patients with advanced gastric cancer. 32 patients with advanced gastric cancer were treated with oral etoposide (100 mg), leucovorin (3 x 100 mg), and tegafur (3 x 200 mg) over 14-21 days for a maximum of six cycles. Objective response was seen in only 5 patients (16%), stable disease was documented in 7 (22%), while the remaining patients progressed during therapy. The median time to progression was 2.8 months (range 0.7-12 months) and median overall survival was 6 months (range 1-18+ months). Due to grade 3 nausea/emesis, 8 patients discontinued treatment prematurely, while 12 patients experienced anorexia and progressive weight loss. Haematological toxicity was modest, with 4 patients developing asymptomatic grade 3-4 granulocytopenia. We conclude that this oral combination regimen cannot be recommended for the treatment of advanced gastric cancer." @default.
- W1990627589 created "2016-06-24" @default.
- W1990627589 creator A5002926775 @default.
- W1990627589 creator A5005197002 @default.
- W1990627589 creator A5007884474 @default.
- W1990627589 creator A5010712142 @default.
- W1990627589 creator A5031817523 @default.
- W1990627589 creator A5048601448 @default.
- W1990627589 creator A5060699000 @default.
- W1990627589 creator A5076684030 @default.
- W1990627589 creator A5080935824 @default.
- W1990627589 date "1998-06-01" @default.
- W1990627589 modified "2023-10-06" @default.
- W1990627589 title "Treatment of advanced gastric cancer with oral etoposide, leucovorin and tegafur: experience with an oral modification of the etoposide, leucovorin and 5-fluorouracil (ELF) regimen" @default.
- W1990627589 cites W1811602282 @default.
- W1990627589 cites W1905936368 @default.
- W1990627589 cites W1984984833 @default.
- W1990627589 cites W2039123736 @default.
- W1990627589 cites W2053670125 @default.
- W1990627589 cites W2130522735 @default.
- W1990627589 cites W2131030742 @default.
- W1990627589 cites W2141121384 @default.
- W1990627589 cites W2262249901 @default.
- W1990627589 doi "https://doi.org/10.1016/s0959-8049(97)10140-x" @default.
- W1990627589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9849466" @default.
- W1990627589 hasPublicationYear "1998" @default.
- W1990627589 type Work @default.
- W1990627589 sameAs 1990627589 @default.
- W1990627589 citedByCount "4" @default.
- W1990627589 crossrefType "journal-article" @default.
- W1990627589 hasAuthorship W1990627589A5002926775 @default.
- W1990627589 hasAuthorship W1990627589A5005197002 @default.
- W1990627589 hasAuthorship W1990627589A5007884474 @default.
- W1990627589 hasAuthorship W1990627589A5010712142 @default.
- W1990627589 hasAuthorship W1990627589A5031817523 @default.
- W1990627589 hasAuthorship W1990627589A5048601448 @default.
- W1990627589 hasAuthorship W1990627589A5060699000 @default.
- W1990627589 hasAuthorship W1990627589A5076684030 @default.
- W1990627589 hasAuthorship W1990627589A5080935824 @default.
- W1990627589 hasBestOaLocation W19906275891 @default.
- W1990627589 hasConcept C121608353 @default.
- W1990627589 hasConcept C126322002 @default.
- W1990627589 hasConcept C141071460 @default.
- W1990627589 hasConcept C2776694085 @default.
- W1990627589 hasConcept C2777299880 @default.
- W1990627589 hasConcept C2778119113 @default.
- W1990627589 hasConcept C2780456651 @default.
- W1990627589 hasConcept C2780580376 @default.
- W1990627589 hasConcept C2781413609 @default.
- W1990627589 hasConcept C71924100 @default.
- W1990627589 hasConcept C90924648 @default.
- W1990627589 hasConceptScore W1990627589C121608353 @default.
- W1990627589 hasConceptScore W1990627589C126322002 @default.
- W1990627589 hasConceptScore W1990627589C141071460 @default.
- W1990627589 hasConceptScore W1990627589C2776694085 @default.
- W1990627589 hasConceptScore W1990627589C2777299880 @default.
- W1990627589 hasConceptScore W1990627589C2778119113 @default.
- W1990627589 hasConceptScore W1990627589C2780456651 @default.
- W1990627589 hasConceptScore W1990627589C2780580376 @default.
- W1990627589 hasConceptScore W1990627589C2781413609 @default.
- W1990627589 hasConceptScore W1990627589C71924100 @default.
- W1990627589 hasConceptScore W1990627589C90924648 @default.
- W1990627589 hasIssue "7" @default.
- W1990627589 hasLocation W19906275891 @default.
- W1990627589 hasLocation W19906275892 @default.
- W1990627589 hasOpenAccess W1990627589 @default.
- W1990627589 hasPrimaryLocation W19906275891 @default.
- W1990627589 hasRelatedWork W1043636449 @default.
- W1990627589 hasRelatedWork W2005022537 @default.
- W1990627589 hasRelatedWork W2074373501 @default.
- W1990627589 hasRelatedWork W2121084046 @default.
- W1990627589 hasRelatedWork W2122228776 @default.
- W1990627589 hasRelatedWork W2350316921 @default.
- W1990627589 hasRelatedWork W2361796614 @default.
- W1990627589 hasRelatedWork W2394842491 @default.
- W1990627589 hasRelatedWork W2470479129 @default.
- W1990627589 hasRelatedWork W3150712416 @default.
- W1990627589 hasVolume "34" @default.
- W1990627589 isParatext "false" @default.
- W1990627589 isRetracted "false" @default.
- W1990627589 magId "1990627589" @default.
- W1990627589 workType "article" @default.